Labrador, Quennie .
HRN: 21-45-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/09/2022
06/15/2022
IVT
75mg
Q24
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes